Literature DB >> 35575113

[Incidence and Risk Factors of Dyslipidemia after Menopause].

Ihn Sook Jeong1, Hae Sun Yun2, Myo Sung Kim3, Youn Sun Hwang4.   

Abstract

PURPOSE: This study was aimed at investigating the incidence and risk factors of dyslipidemia in menopausal women using a Korean community-based longitudinal study.
METHODS: The subjects were 245 postmenopausal women without dyslipidemia who had participated in the Ansan-Ansung cohort study from 2001~2002 (baseline) to 2015~2016 (seventh follow-up visit). The dyslipidemia incidence was measured as incidence proportion (%) and incidence rate per 100 person-years. The predictors of developing dyslipidemia were analyzed with Cox's proportional hazard model.
RESULTS: The incidence of new dyslipidemia during the follow-up period was 78.4% (192 patients), and 11.9 per 100 person-years. Mean duration from menopause to developing dyslipidemia was 5.3 years in new dyslipidemia cases. The triglyceride/high density lipoprotein (TG/HDL-C) ratio at baseline (hazard ratio = 2.20; 95% confidence interval = 1.39~3.48) was independently associated with developing dyslipidemia.
CONCLUSION: Dyslipidemia occurs frequently in postmenopausal women, principally within five years after menopause. Therefore, steps must be taken to prevent dyslipidemia immediately after menopause, particularly in women with a high TG/HDL-C ratio at the start of menopause.
© 2022 Korean Society of Nursing Science.

Entities:  

Keywords:  Dyslipidemias; Incidence; Menopause; Risk Factors

Mesh:

Substances:

Year:  2022        PMID: 35575113     DOI: 10.4040/jkan.21188

Source DB:  PubMed          Journal:  J Korean Acad Nurs        ISSN: 2005-3673            Impact factor:   0.984


  34 in total

Review 1.  Metabolic Syndrome and Menopause: Pathophysiology, Clinical and Diagnostic Significance.

Authors:  Anna Stefanska; Katarzyna Bergmann; Grazyna Sypniewska
Journal:  Adv Clin Chem       Date:  2015-08-21       Impact factor: 5.394

2.  Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors.

Authors:  Angelo Cagnacci; Marianna Cannoletta; Simona Caretto; Renata Zanin; Anjeza Xholli; Annibale Volpe
Journal:  Menopause       Date:  2011-03       Impact factor: 2.953

3.  Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women.

Authors:  Yuni Choi; Yoosoo Chang; Bo-Kyoung Kim; Danbee Kang; Min-Jung Kwon; Chan-Won Kim; Chul Jeong; Younjhin Ahn; Hyun-Young Park; Seungho Ryu; Juhee Cho
Journal:  Maturitas       Date:  2015-01-10       Impact factor: 4.342

Review 4.  Metabolic syndrome in menopause and associated factors: a meta-analysis.

Authors:  D Pu; R Tan; Q Yu; J Wu
Journal:  Climacteric       Date:  2017-10-24       Impact factor: 3.005

5.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Authors:  François Mach; Colin Baigent; Alberico L Catapano; Konstantinos C Koskinas; Manuela Casula; Lina Badimon; M John Chapman; Guy G De Backer; Victoria Delgado; Brian A Ference; Ian M Graham; Alison Halliday; Ulf Landmesser; Borislava Mihaylova; Terje R Pedersen; Gabriele Riccardi; Dimitrios J Richter; Marc S Sabatine; Marja-Riitta Taskinen; Lale Tokgozoglu; Olov Wiklund
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

Review 6.  Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis.

Authors:  Oscar H Franco; Taulant Muka; Veronica Colpani; Setor Kunutsor; Susmita Chowdhury; Rajiv Chowdhury; Maryam Kavousi
Journal:  Maturitas       Date:  2015-05-12       Impact factor: 4.342

7.  Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.

Authors:  Julian P Halcox; José R Banegas; Carine Roy; Jean Dallongeville; Guy De Backer; Eliseo Guallar; Joep Perk; David Hajage; Karin M Henriksson; Claudio Borghi
Journal:  BMC Cardiovasc Disord       Date:  2017-06-17       Impact factor: 2.298

8.  Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: A cross-sectional analysis.

Authors:  Sunjoo Boo; Young Joo Yoon; Hyunjin Oh
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

Review 9.  Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.

Authors:  Panagiotis Anagnostis; Johannes Bitzer; Antonio Cano; Iuliana Ceausu; Peter Chedraui; Fatih Durmusoglu; Risto Erkkola; Dimitrios G Goulis; Angelica Lindén Hirschberg; Ludwig Kiesel; Patrice Lopes; Amos Pines; Mick van Trotsenburg; Irene Lambrinoudaki; Margaret Rees
Journal:  Maturitas       Date:  2020-03-16       Impact factor: 4.342

10.  Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.

Authors:  Yuan Lu; Pei Wang; Tianna Zhou; Jiapeng Lu; Erica S Spatz; Khurram Nasir; Lixin Jiang; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.